Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Border

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1984
Anticoagulants are of little value in the treatment of renal diseaseW A Border
Current Opinion in Nephrology and Hypertension|January 1, 1994
Transforming growth factor-beta and the pathogenesis of glomerular diseasesW A Border
Nephron|January 1, 1979
Immune complex detection in glomerular diseasesW A Border
Kidney International|September 1, 1988
Distinguishing minimal-change disease from mesangial disordersW A Border
Seminars in Nephrology|December 26, 2001
Maximizing hemodynamic-independent effects of angiotensin II antagonists in fibrotic diseasesW A Border, N Noble
The Journal of Clinical Investigation|July 1, 1992
Transforming growth factor-beta in disease: the dark side of tissue repairW A Border, E Ruoslahti
Cell Differentiation and Development : the Official Journal of the International Society of Developmental Biologists|December 2, 1990
Transforming growth factor-beta 1 induces extracellular matrix formation in glomerulonephritisW A Border, E Ruoslahti
Seminars in Nephrology|October 8, 1997
Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target?N A Noble, W A Border
Hypertension (Dallas, Tex. : 1979)|February 7, 1998
Interactions of transforming growth factor-beta and angiotensin II in renal fibrosisW A Border, N A Noble
Kidney International|May 1, 1997
TGF-beta in kidney fibrosis: a target for gene therapyW A Border, N A Noble
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1984
Anticoagulants are of little value in the treatment of renal diseaseW A Border
Current Opinion in Nephrology and Hypertension|January 1, 1994
Transforming growth factor-beta and the pathogenesis of glomerular diseasesW A Border
Nephron|January 1, 1979
Immune complex detection in glomerular diseasesW A Border
Kidney International|September 1, 1988
Distinguishing minimal-change disease from mesangial disordersW A Border
Seminars in Nephrology|December 26, 2001
Maximizing hemodynamic-independent effects of angiotensin II antagonists in fibrotic diseasesW A Border, N Noble
The Journal of Clinical Investigation|July 1, 1992
Transforming growth factor-beta in disease: the dark side of tissue repairW A Border, E Ruoslahti
Cell Differentiation and Development : the Official Journal of the International Society of Developmental Biologists|December 2, 1990
Transforming growth factor-beta 1 induces extracellular matrix formation in glomerulonephritisW A Border, E Ruoslahti
Seminars in Nephrology|October 8, 1997
Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target?N A Noble, W A Border
Hypertension (Dallas, Tex. : 1979)|February 7, 1998
Interactions of transforming growth factor-beta and angiotensin II in renal fibrosisW A Border, N A Noble
Kidney International|May 1, 1997
TGF-beta in kidney fibrosis: a target for gene therapyW A Border, N A Noble
Pageof 11